BDNF treatment abolished cisplatin-induced cell death and reduced the chemosensitivity of neuroblastoma cells to cisplatin, an effect that was blocked by treatment of cells with the PI3K inhibitor, LY294002, indicating a role of PI3K in BDNF’s rescue effects [41]. This evidence concerns the gene BDNF and neuroblastoma.